171 related articles for article (PubMed ID: 2596572)
1. Endothelial-cell injury in cutaneous acute graft-versus-host disease.
Dumler JS; Beschorner WE; Farmer ER; Di Gennaro KA; Saral R; Santos GW
Am J Pathol; 1989 Dec; 135(6):1097-103. PubMed ID: 2596572
[TBL] [Abstract][Full Text] [Related]
2. Endothelial changes in cutaneous graft-versus-host disease: a comparison between HLA matched and mismatched recipients of bone marrow transplantation.
Sviland L; Sale GE; Myerson D
Bone Marrow Transplant; 1991 Jan; 7(1):35-8. PubMed ID: 2043875
[TBL] [Abstract][Full Text] [Related]
3. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease.
Biedermann BC; Sahner S; Gregor M; Tsakiris DA; Jeanneret C; Pober JS; Gratwohl A
Lancet; 2002 Jun; 359(9323):2078-83. PubMed ID: 12086762
[TBL] [Abstract][Full Text] [Related]
4. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
[TBL] [Abstract][Full Text] [Related]
5. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
6. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
7. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature.
Esteban JM; Somlo G
Mod Pathol; 1995 Jan; 8(1):59-64. PubMed ID: 7731943
[TBL] [Abstract][Full Text] [Related]
8. The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables.
Elliott CJ; Sloane JP; Sanderson KV; Vincent M; Shepherd V; Powles R
Histopathology; 1987 Feb; 11(2):145-55. PubMed ID: 3552928
[TBL] [Abstract][Full Text] [Related]
9. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease.
Kohler S; Hendrickson MR; Chao NJ; Smoller BR
Am J Surg Pathol; 1997 Sep; 21(9):988-96. PubMed ID: 9298874
[TBL] [Abstract][Full Text] [Related]
10. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
Firoz BF; Lee SJ; Nghiem P; Qureshi AA
Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous graft-versus-host reaction: prognostic features seen by light microscopy.
Hymes SR; Farmer ER; Lewis PG; Tutschka PJ; Santos GW
J Am Acad Dermatol; 1985 Mar; 12(3):468-74. PubMed ID: 3989008
[TBL] [Abstract][Full Text] [Related]
12. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease.
Biedermann BC; Tsakiris DA; Gregor M; Pober JS; Gratwohl A
Bone Marrow Transplant; 2003 Dec; 32(11):1077-84. PubMed ID: 14625579
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous leucocyte composition after human allogeneic bone marrow transplantation: relationship to marrow purging, histology and clinical rash.
Elliott CJ; Sloane JP; Pallett CD; Sanderson KV
Histopathology; 1988 Jan; 12(1):1-16. PubMed ID: 3286467
[TBL] [Abstract][Full Text] [Related]
14. In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD.
Sackstein R; Messina JL; Elfenbein GJ
Blood; 2003 Jan; 101(2):771-8. PubMed ID: 12393384
[TBL] [Abstract][Full Text] [Related]
15. LN-3: a diagnostic adjunct in cutaneous graft-versus-host disease.
Synovec MS; Braddock SW; Jones J; Linder J
Mod Pathol; 1990 Nov; 3(6):643-7. PubMed ID: 1702211
[TBL] [Abstract][Full Text] [Related]
16. Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
Hillen U; Häusermann P; Massi D; Janin A; Wolff D; Lawitschka A; Greinix H; Meyer R; Ziemer M
J Eur Acad Dermatol Venereol; 2015 May; 29(5):948-54. PubMed ID: 25265987
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelium and graft-versus-host disease.
Biedermann BC
Best Pract Res Clin Haematol; 2008 Jun; 21(2):129-38. PubMed ID: 18503981
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal expression of CD34 and cell adhesion molecule ELAM-1 on vascular endothelium in acute cutaneous graft-versus-host disease.
Norton J; Sloane JP; Delia D; Greaves MF
J Pathol; 1993 Jun; 170(2):173-7. PubMed ID: 7688420
[TBL] [Abstract][Full Text] [Related]
19. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
